Stock data
Caris Life Sciences, Inc. (CAI)
Caris Life Sciences, Inc. (CAI) reported revenue of US$812.03M and net income of -US$68.09M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$812.03M | — | US$45.11M | -US$68.09M | — |
| 2024 | US$412.26M | — | -US$257.12M | -US$281.89M | — |
| 2023 | US$306.13M | — | -US$319.55M | -US$341.42M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$263.71M | -US$0.64M | — |
| 2026-03-31 | US$216.17M | -US$0.51M | — |
| 2025-12-31 | US$292.89M | US$81.96M | — |
| 2025-09-30 | US$216.83M | US$24.32M | — |
| 2025-06-30 | US$181.40M | -US$71.79M | — |
| 2025-03-31 | US$120.92M | -US$102.58M | — |
| 2024-09-30 | US$101.62M | -US$67.73M | — |
| 2024-06-30 | US$100.05M | -US$66.19M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.